VPS26B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.862000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.011000E-01
Normal-vs-Stage2
8.811000E-01
Normal-vs-Stage3
2.782400E-01
Normal-vs-Stage4
8.844600E-01
Stage1-vs-Stage2
4.063600E-02
Stage1-vs-Stage3
2.611800E-02
Stage1-vs-Stage4
4.154400E-01
Stage2-vs-Stage3
9.211900E-02
Stage2-vs-Stage4
6.494600E-01
Stage3-vs-Stage4
2.472400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.963000E-01
Normal-vs-AfricanAmerican
7.535000E-01
Normal-vs-Asian
9.236400E-01
Caucasian-vs-AfricanAmerican
6.311600E-01
Caucasian-vs-Asian
8.233200E-01
AfricanAmerican-vs-Asian
6.088000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.172800E-01
Normal-vs-Female
8.770600E-01
Male-vs-Female
3.110600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.995000E-01
Normal-vs-Age(41-60Yrs)
6.359200E-01
Normal-vs-Age(61-80Yrs)
8.730600E-01
Normal-vs-Age(81-100Yrs)
6.488000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.720200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.241400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.730300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.991800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.820200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.331400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.735000E-01
Normal-vs-Daily Drinker
9.351800E-01
Normal-vs-Weekly Drinker
9.782000E-01
Normal-vs-Occasional Drinker
8.550000E-01
Normal-vs-Social Drinker
6.648000E-01
Non Drinker-vs-Daily Drinker
4.812200E-01
Non Drinker-vs-Weekly Drinker
4.441400E-01
Non Drinker-vs-Occasional Drinker
2.402000E-01
Non Drinker-vs-Social Drinker
1.024440E-01
Daily Drinker-vs-Weekly Drinker
9.130400E-01
Daily Drinker-vs-Occasional Drinker
5.931800E-01
Daily Drinker-vs-Social Drinker
3.524200E-01
Weekly Drinker-vs-Occasional Drinker
6.904600E-01
Weekly Drinker-vs-Social Drinker
4.144400E-01
Occasional Drinker-vs-Social Drinker
7.824600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.753390E-01
Normal-vs-Grade 2
1.837940E-02
Normal-vs-Grade 3
4.575000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.098800E-01
Grade 1-vs-Grade 3
7.974600E-01
Grade 1-vs-Grade 4
1.753390E-01
Grade 2-vs-Grade 3
7.782400E-01
Grade 2-vs-Grade 4
1.837940E-02
Grade 3-vs-Grade 4
4.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.640800E-01
Normal-vs-NonDiabetic
8.971600E-01
Diabetic-vs-NonDiabetic
8.066200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.190400E-01
Normal-vs-NoPancreatitis
9.426400E-01
Pancreatitis-vs-NoPancreatitis
1.232360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.412600E-01
Normal-vs-N1
8.713200E-01
N0-vs-N1
9.400200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.586200E-01
Normal-vs-TP53-NonMutant
7.729600E-01
TP53-Mutant-vs-TP53-NonMutant
5.203600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
